First assessment of the performance of an implantable continuous glucose monitoring system through 180 days in a primarily adolescent population with type 1 diabetes

por Aronson, Ronnie, Abitbol, Alexander, Tweden, Katherine S.
Publicado 2019

Real-World Safety of an Implantable Continuous Glucose Sensor Over Multiple Cycles of Use: A Post-Market Registry Study

por Deiss, Dorothee, Irace, Concetta, Carlson, Grace, Tweden, Katherine S., Kaufman, Francine R.
Publicado 2020

Longitudinal Analysis of Real-World Performance of an Implantable Continuous Glucose Sensor over Multiple Sensor Insertion and Removal Cycles

por Tweden, Katherine S., Deiss, Dorothee, Rastogi, Ravi, Addaguduru, Suresh, Kaufman, Francine R.
Publicado 2020

A Prospective Multicenter Evaluation of the Accuracy and Safety of an Implanted Continuous Glucose Sensor: The PRECISION Study

por Christiansen, Mark P., Klaff, Leslie J., Bailey, Timothy S., Brazg, Ronald, Carlson, Grace, Tweden, Katherine S.
Publicado 2019

Two-Year Outcomes of Vagal Nerve Blocking (vBloc) for the Treatment of Obesity in the ReCharge Trial

por Apovian, Caroline M., Shah, Sajani N., Wolfe, Bruce M., Ikramuddin, Sayeed, Miller, Christopher J., Tweden, Katherine S., Billington, Charles J., Shikora, Scott A.
Publicado 2016

Effect of Vagal Nerve Blockade on Moderate Obesity with an Obesity-Related Comorbid Condition: the ReCharge Study

por Morton, John M., Shah, Sajani N., Wolfe, Bruce M., Apovian, Caroline M., Miller, Christopher J., Tweden, Katherine S., Billington, Charles J., Shikora, Scott A.
Publicado 2016

Evaluation of Accuracy and Safety of the Next-Generation Up to 180-Day Long-Term Implantable Eversense Continuous Glucose Monitoring System: The PROMISE Study

por Garg, Satish K., Liljenquist, David, Bode, Bruce, Christiansen, Mark P., Bailey, Timothy S., Brazg, Ronald L., Denham, Douglas S., Chang, Anna R., Akturk, Halis Kaan, Dehennis, Andrew, Tweden, Katherine S., Kaufman, Francine R.
Publicado 2022

Clinical use of a 180‐day implantable glucose sensor improves glycated haemoglobin and time in range in patients with type 1 diabetes

por Irace, Concetta, Cutruzzolà, Antonio, Nuzzi, Annamaria, Assaloni, Roberta, Brunato, Barbara, Pitocco, Dario, Tartaglione, Linda, Di Molfetta, Sergio, Cignarelli, Angelo, Laviola, Luigi, Citro, Giuseppe, Lovati, Elisabetta, Gnasso, Agostino, Tweden, Katherine S, Kaufman, Francine R
Publicado 2020

Sustained Weight Loss with Vagal Nerve Blockade but Not with Sham: 18-Month Results of the ReCharge Trial

por Shikora, Scott A., Wolfe, Bruce M., Apovian, Caroline M., Anvari, Mehran, Sarwer, David B., Gibbons, Robert D., Ikramuddin, Sayeed, Miller, Christopher J., Knudson, Mark B., Tweden, Katherine S., Sarr, Michael G., Billington, Charles J.
Publicado 2015